Heron Therapeutics
HRTX
189 hedge funds and large institutions have $1.91B invested in Heron Therapeutics in 2020 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 52 increasing their positions, 64 reducing their positions, and 19 closing their positions.
145% more call options, than puts
Call options by funds: $2.94M | Put options by funds: $1.2M
42% more capital invested
Capital invested by funds: $1.34B → $1.91B (+$567M)
37% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 19
4% more funds holding
Funds holding: 182 → 189 (+7)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
0.63% less ownership
Funds ownership: 99.99% → 99.36% (-0.63%)
19% less repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 64
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$57.7M |
| 2 |
BlackRock
New York
|
+$18.4M |
| 3 |
ITP
Iron Triangle Partners
Cos Cob,
Connecticut
|
+$15M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$9.38M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tang Capital Management
San Diego,
California
|
-$42.9M |
| 2 |
CCM
Consonance Capital Management
New York
|
-$29.7M |
| 3 |
KCM
Kensico Capital Management
Greenwich,
Connecticut
|
-$8.03M |
| 4 |
State Street
Boston,
Massachusetts
|
-$7.45M |
| 5 |
Fidelity International
Hamilton,
Bermuda
|
-$7.13M |
HRTX Hedge Fund Activity: Q4 2020 in Review
189 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Heron Therapeutics (HRTX) for Q4 2020, worth a combined $1.91B — up 42% from $1.34B a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new HRTX positions and 19 closed out — a net gain of 7 holders — while 52 added to existing stakes and 64 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $57.7M. The largest seller was Tang Capital Management, exiting entirely with an estimated $42.9M sold.
- 189 institutional investors held Heron Therapeutics (HRTX) as of Q4 2020, up from 182 in Q3 2020.
- Funds reported $1.91B of Heron Therapeutics stock for Q4 2020, up 42% quarter-over-quarter.
- 26 funds opened new Heron Therapeutics positions in Q4 2020 and 19 closed out, a net change of +7 holders.
- The largest Heron Therapeutics buyer in Q4 2020 was Wellington Management Group, an estimated $57.7M added.
- The largest Heron Therapeutics seller in Q4 2020 was Tang Capital Management, an estimated $42.9M sold.
Based on aggregated 13F filings for Q4 2020.